MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2016 International Congress

    Gait and cognition: Mapping the global and discrete relationships in ageing and neurodegenerative disease

    R. Morris, S. Lord, J. Bunce, D. Burn, L. Rochester (Newcastle-Upon-Tyne, United Kingdom)

    Objective: To explore current evidence of associations and predictors of gait and cognition in older adults and pathology to provide a clear understanding of current…
  • 2016 International Congress

    A proposed Parkinson’s disease neuropsychological battery (PNB)

    L.L. van Wanrooij, J. Hoogland, J.G. Goldman, G. Stebbins, G.J. Geurtsen, D. Weintraub (Amsterdam, Netherlands)

    Objective: To propose a neuropsychological battery for assessing cognitive abilities in Parkinson's disease (PD) that also fulfills proposed MDS diagnostic criteria for PD mild cognitive…
  • 2016 International Congress

    Are limbic and cognitive effects on balance in Parkinson’s disease equal?

    K.A. Ehgoetz Martens, C.G. Ellard, Q.J. Almeida (Camperdown, Australia)

    Objective: The main objective of this study was to evaluate: (i)whether highly anxious PD (HA-PD) have a reduced capacity for information processing compared to PD…
  • 2016 International Congress

    Fall prediction in Parkinson’s disease based on motor dual-tasking: Evidence from the prospective MODEP study

    S. Heinzel, M. Maechtel, S.E. Hasmann, M.A. Hobert, T. Heger, D. Berg, W. Maetzler (Tübingen, Germany)

    Objective: To evaluate the predictive value of dual-task performance for future falls in patients with Parkinson's disease (PD). Background: Falls entail very severe health-related consequences…
  • 2016 International Congress

    The cognitive profile of idiopathic REM sleep behavior disorder

    L. Bernier-Lalonger, F. Escudier, P.A. Bourgouin, R.B. Postuma, J. Montplaisir, J.F. Gagnon (Montreal, QC, Canada)

    Objective: The aim of this study was to examine the cognitive profile in a large cohort of patients with idiopathic REM sleep behavior disorder (iRBD).…
  • 2016 International Congress

    Predicting therapeutic effects of atomoxetine and citalopram on response inhibition in Parkinson’s disease

    J.B. Rowe, C. Rae, C. Nombela, T. Ham, P. Vazquez, I. Coyle-Gilchrist, C.R. Housden, B.J. Sahakian, T.W. Robbins, Z. Yes (Cambridge, United Kingdom)

    Objective: (1) To reassess the behavioral impact of novel noradrenergic (atomoxetine) and serotonergic (citalopram) therapies for impulsivity and (2) to develop predictive models to identify…
  • 2016 International Congress

    Cognitive outcome in the patients with Parkinson’s disease one year after subthalamic implants in Taiwan

    Y.F. Chen, C.C. Chang, W.F. Chen, F.Y. Shih, M.Y. Lan, T.K. Lin, Y.F. Chen, Y.Y. Chang (Kaohsiung, Taiwan)

    Objective: To demonstrate cognitive outcome after subthalamic deep brain stimulation(DBS) in the patients with Parkinson's disease(PD) in Taiwan. Background: Deep brain stimulation of the subthalamic…
  • 2016 International Congress

    The relationship between the cognitive phenotype and 5-HT2A receptor in PD with visual hallucinations

    S.S. Cho, A.P. Strafella, S. Duff-Canning, M. Zurowski, A.C. Vijverman, V. Bruno, C. de Aquino, M. Criaud, P.M. Rusjan, S. Houle, S.H. Fox (Toronto, ON, Canada)

    Objective: The aim of this study was to investigate the relationship between cognitive phenotype and 5-HT2A receptor availability in PD patients with visual hallucinations (VH).…
  • 2016 International Congress

    Parkinson’s disease characteristics in patients with Gaucher’s disease

    A. Thaler, A. Mirelman, E. Shimoni, M. Victor, O. Assais, M. Grumberg, T. Gurevich, T. Shiner, M. Gana Weisz, A. Orr Urtreger, N. Giladi (Tel-Aviv, Israel)

    Objective: To assess the phenotype of Parkinson's disease (PD) patients in homozygote or compound heterozygote carriers of mutations in the β-glucocerebrosidase gene (GBA). Background: Gaucher's…
  • 2016 International Congress

    Gustatory function of patients with essential tremor and its correlation with olfactory and cognitive functions

    M.G. Senol, H. Tekeli, M. Saglam, E. Arslanoglu (Istanbul, Turkey)

    Objective: We aimed to evaluate gustatory, olfactory and cognitive functions in Essential Tremor patients. Background: Essential tremor (ET) is a pathologically heterogeneous neurodegenerative disorder with…
  • « Previous Page
  • 1
  • …
  • 110
  • 111
  • 112
  • 113
  • 114
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley